Mr. Bart Eugene Barto, L.P.A. Psychologist - Clinical Medicare: Not Enrolled in Medicare Practice Location: 10112 W County Road 54, Midland, TX 79707 Phone: 432-563-1363 Fax: 432-563-1363 |
Dr. Paula Shantel Alexis Mackey, PSY.D. Psychologist - Clinical Medicare: Not Enrolled in Medicare Practice Location: 3309 Haynes Ave, Midland, TX 79707 Phone: 512-535-8433 Fax: 432-242-0982 |
Mr. Charles N Silverman, MASTERS Psychologist Medicare: Not Enrolled in Medicare Practice Location: 6 Desta Dr Ste 2565, Midland, TX 79705 Phone: 432-682-2925 Fax: 432-687-6022 |
Dr. Janet Alaine Carter, PHD Psychologist Medicare: Not Enrolled in Medicare Practice Location: 4214 Andrews Hwy, Midland, TX 79703 Phone: 432-686-6600 |
Jane Ashley Cain, M.ED. DIAGNOSTICIAN Psychologist - Mental Retardation & Developmental Disabilities Medicare: Not Enrolled in Medicare Practice Location: 10 Desta Dr, Suite 184-w, Midland, TX 79705 Phone: 432-894-0771 |
Barbara A Brucken, PH.D. Psychologist Medicare: Not Enrolled in Medicare Practice Location: 2104 W Michigan Ave, Midland, TX 79701 Phone: 432-570-9552 Fax: 432-570-9859 |
Perry M Marchioni, PHD Psychologist Medicare: Not Enrolled in Medicare Practice Location: 1705 W Illinois, Midland, TX 79701 Phone: 432-684-4540 Fax: 432-685-0809 |
Dr. Lisa D Bayley, PH.D. Psychologist - Clinical Child & Adolescent Medicare: Medicare Enrolled Practice Location: 2301 W Michigan Ave, Midland, TX 79701 Phone: 432-620-1160 |
Dr. David Allan Koch, PH.D. Psychologist - Clinical Medicare: Not Enrolled in Medicare Practice Location: 6 Desta Dr, Suite 3340, Midland, TX 79705 Phone: 432-684-8113 Fax: 432-570-5035 |
Mark Adams Troschinetz, LCDC, SAP, ADC, CART Psychologist - Counseling Medicare: Not Enrolled in Medicare Practice Location: 3106 W Kentucky Ave, Midland, TX 79701 Phone: 432-557-6921 Fax: 888-804-2543 |
Bill Sigsbee Psychologist - Clinical Medicare: Not Enrolled in Medicare Practice Location: 207 Tradewinds Blvd, Suite 110, Midland, TX 79706 Phone: 432-289-7235 Fax: 432-689-0227 |
News Archive
The U.S. Food and Drug Administration has approved a novel genetic test for determining whether patients with breast cancer are good candidates for treatment with the drug Herceptin (trastuzumab).
BSD Medical Corporation today announced the inclusion of hyperthermia and chemotherapy as a recommended cancer treatment for Stage IV sarcomas in the "Practice Guidelines in Oncology", which is issued by the National Comprehensive Cancer Network.
Urinary catheters are often left in place longer than needed, and new research shows that reminder systems that encourage hospital staff to remove catheters promptly can reduce the rate of catheter-associated urinary tract infections by 52 percent.
Apexigen, Inc., a biopharmaceutical company discovering and developing innovative antibody drugs for the treatment of cancer and other life-threatening diseases, announced today the initiation of a Phase 1 clinical trial of APX005M, the company's lead proprietary anticancer program.
U.S. and German scientists have decoded a key molecular gateway for the toxin that causes botulism, pointing the way to treatments that can keep the food-borne poison out of the bloodstream.
› Verified 9 days ago